{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:00:53Z","timestamp":1793818853344,"version":"4.6.1"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1001\/jamadermatol.2019.4835","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T16:31:39Z","timestamp":1580920299000},"page":"384","source":"Crossref","is-referenced-by-count":45,"title":["A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents"],"prefix":"10.1001","volume":"156","author":[{"given":"Inge M. G. J.","family":"Bronckers","sequence":"first","affiliation":[{"name":"Department of Dermatology, Radboud University, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University, Chicago, Illinois"},{"name":"Department of Pediatrics, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"West","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwestern University, Chicago, Illinois"},{"name":"Department of Pediatrics, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lara-Corrales","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Dermatology Section, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha M.","family":"Tollefson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynnis L.","family":"Tom","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rady Children\u2019s Hospital San Diego, University of California, San Diego"},{"name":"Department of Pediatrics, Rady Children\u2019s Hospital San Diego, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Hogeling","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Phoenix Children\u2019s Hospital, Phoenix, Arizona"},{"name":"now with the Department of Dermatology, UCLA (University of California, Los Angeles)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Belazarian","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Herlev-Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mah\u00e9","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Victor Dupouy Argenteuil, Argenteuil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Siegfried","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St Louis University School of Medicine, St Louis, Missouri"},{"name":"Department of Pediatrics, St Louis University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Blume-Peytavi","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Charit\u00e9- Universit\u00e4tsmedizin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Szalai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Heim P\u00e1l Children\u2019s Hospital, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical College of Wisconsin, Milwaukee"},{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Murphy","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department, Nottingham University Hospitals, Nottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Cordoro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco Medical Center, San Francisco"},{"name":"Department of Pediatrics, University of California, San Francisco Medical Center, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Alexopoulos","sequence":"additional","affiliation":[{"name":"First Department of Pediatrics, Agia Sofia Children\u2019s Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mrowietz","sequence":"additional","affiliation":[{"name":"Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietske","family":"Kievit","sequence":"additional","affiliation":[{"name":"Department for Health Evidence, Radboud University, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M. B.","family":"Seyger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Radboud University, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Psoriasis Investigator Group, the Pediatric Dermatology Research Alliance, and the European Working Group on Pediatric Psoriasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9997","key":"doi190077r1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis.","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"doi190077r2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","article-title":"Psoriasis in children and adolescents.","volume":"17","author":"Bronckers","year":"2015","journal-title":"Paediatr Drugs"},{"issue":"2","key":"doi190077r3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/pde.2018.35.issue-2","article-title":"Pediatric psoriasis.","volume":"35","author":"Eichenfield","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"doi190077r4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1001\/jamadermatol.2017.3029","article-title":"Safety of systemic agents for the treatment of pediatric psoriasis.","volume":"153","author":"Bronckers","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"5","key":"doi190077r5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/09546634.2014.996515","article-title":"Methotrexate in pediatric plaque-type psoriasis.","volume":"26","author":"van Geel","year":"2015","journal-title":"J Dermatolog Treat"},{"issue":"10089","key":"doi190077r6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(17)31189-3","article-title":"Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis.","volume":"390","author":"Papp","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"doi190077r7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa066886","article-title":"Etanercept treatment for children and adolescents with plaque psoriasis.","volume":"358","author":"Paller","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"doi190077r8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaad.2010.04.004","article-title":"Long-term etanercept in pediatric patients with plaque psoriasis.","volume":"63","author":"Paller","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi190077r9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2015.09.056","article-title":"Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis.","volume":"74","author":"Paller","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"doi190077r10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","article-title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.","volume":"73","author":"Landells","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi190077r16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14740338.2018.1391787","article-title":"Biologics in pediatric psoriasis.","volume":"17","author":"Dogra","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"doi190077r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jid.2015.171","article-title":"Drug survival studies in dermatology.","volume":"135","author":"van den Reek","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi190077r18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjd.2014.170.issue-2","article-title":"Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis.","volume":"170","author":"van den Reek","year":"2014","journal-title":"Br J Dermatol"},{"issue":"11","key":"doi190077r19","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1038\/jid.2015.208","article-title":"Differential drug survival of biologic therapies for the treatment of psoriasis.","volume":"135","author":"Warren","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"doi190077r20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jid.2017.09.044","article-title":"Differential drug survival of second-line biologic therapies in patients with psoriasis.","volume":"138","author":"Iskandar","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi190077r21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bjd.16102","article-title":"Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis.","volume":"178","author":"Egeberg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi190077r22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjd.2015.172.issue-1","article-title":"Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.","volume":"172","author":"Gniadecki","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi190077r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus.","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"10068","key":"doi190077r24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(16)32127-4","article-title":"An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP).","volume":"389","author":"Warren","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"doi190077r25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jaad.2019.08.049","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi190077r27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09546634.2017.1364692","article-title":"Effectiveness of etanercept in children with plaque psoriasis in real practice.","volume":"29","author":"Di Lernia","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"doi190077r28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/jde.2017.44.issue-6","article-title":"Efficacy, safety and drug survival of conventional agents in pediatric psoriasis.","volume":"44","author":"Ergun","year":"2017","journal-title":"J Dermatol"},{"issue":"10","key":"doi190077r29","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/jdv.v33.10","article-title":"Biological treatments for paediatric psoriasis.","volume":"33","author":"Phan","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi190077r11","unstructured":"Annex 1: summary of product characteristics. http:\/\/www.Ema.Europa.Eu\/docs\/en_gb\/document_library\/epar_-_product_information\/human\/000262\/wc500027361.pdf. Accessed January 2, 2020."},{"key":"doi190077r12","unstructured":"Annex 1: summary of product characteristics. http:\/\/www.Ema.Europa.Eu\/docs\/en_gb\/document_library\/epar_-_product_information\/human\/000481\/wc500050870.pdf. Accessed January 2, 2020."},{"key":"doi190077r13","unstructured":"Annex 1: summary of product characteristics.? http:\/\/www.Ema.Europa.Eu\/docs\/en_gb\/document_library\/epar_-_product_information\/human\/000958\/wc500058513.pdf. Accessed January 2, 2020."},{"key":"doi190077r14","unstructured":"Janssen-cilag. International nv. Stelara (ustekinumab) summary of product information. http:\/\/www.Accessdata.Fda.Gov\/scripts\/sda\/sddetailnavigation.Cfm?Sd=labelingdatabase&id=5fc208c3e462360ce053564da8c088b7&rownum=1. Accessed January 2, 2020."},{"key":"doi190077r15","unstructured":"Highlights of prescribing information. http:\/\/www.Accessdata.Fda.Gov\/drugsatfda_docs\/label\/2016\/103795s5552lbl.pdf. Accessed January 2, 2020."},{"key":"doi190077r26","unstructured":"Dutch Association of Dermatology. Dutch 3 guidelines on psoriasis. http:\/\/www.Nvdv.Nl\/wp-content\/uploads\/2014\/08\/20190515_definitieve-versie-richlijnherziening-psoriasis-2017.Pdf. Published 2017. Accessed January 2, 2020."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2759774\/jamadermatology_bronckers_2020_oi_190077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T15:02:04Z","timestamp":1586358124000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2759774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.4835","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}